Patients with severe asthma required fewer steroid bursts with tezepelumab-ekko, according to a poster presented at the 2025 American Academy of Allergy, Asthma & Immunology/World Allergy Organization ...
If you have moderate to severe asthma, your lungs may have ... Your doctor will help determine the treatment plan that fits your needs. Dupixent reduces inflammation in your body, including ...
Nucala and Dupixent are recommended as treatment options for asthma in guidelines from the Global Initiative for Asthma. Both drugs are also listed as treatment options for CRwNP in guidance from ...
Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils ...
Press Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD
asthma, chronic rhinosinusitis with nasal polyposis (CRSwNP), prurigo nodularis, and chronic spontaneous urticaria (CSU). Dupixent for the treatment of COPD has been approved in more than 45 ...
Dupixent reduces lung inflammation and can help some people with asthma reduce corticosteroid ... Dupixent as an add-on to your existing COPD treatment. How fast Dupixent starts to work depends ...
asthma, chronic rhinosinusitis with nasal polyposis (CRSwNP), prurigo nodularis and chronic spontaneous urticaria (CSU). Dupixent for the treatment of COPD has been approved in more than 45 ...
Press Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD
Dupixent approved as the first-ever biologic medicine in Japan for patients with COPDFollowing recent approvals in the EU, China, and the US, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results